ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,236.40
      1.52%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.02%
      Bitcoin
      63,821.58
      -1.03%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Clearside Biomedical Inc (CLSD)

      7. Clearside Biomedical Inc (CLSD) News

      CLSD Clearside Biomedical Inc

      1.37
      0.11 (8.73%)
      After Hours
      Last Updated: 17:37:12
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Clearside Biomedical Inc CLSD NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.11 8.73% 1.37 17:37:12
      Open Price Low Price High Price Close Price Prev Close
      1.27 1.27 1.38 1.34 1.26
      more quote information »

      Recent News

      Date Time Source Heading
      4/16/202407:05GLOBEClearside Biomedical Appoints Seasoned Biotechnology..
      4/02/202407:05GLOBEClearside Biomedical to Participate in Fireside Chat at the..
      3/18/202407:05GLOBEClearside Biomedical Appoints Victor Chong, M.D., MBA as..
      3/12/202416:05GLOBEClearside Biomedical Announces Fourth Quarter and Full Year..
      2/29/202407:05GLOBEClearside Biomedical to Report Fourth Quarter and Full Year..
      2/08/202417:05EDGAR2Form 8-K - Current report
      2/08/202416:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      2/07/202408:00GLOBEClearside Biomedical Announces Pricing of $15 Million..
      2/01/202416:01EDGAR2Form 8-K - Current report
      1/19/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202415:04EDGAR2Form 144 - Report of proposed sale of securities
      12/28/202316:10EDGAR2Form 8-K - Current report
      12/14/202307:05GLOBEClearside Biomedical Reports Significant Progress in ODYSSEY..
      11/13/202316:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/13/202316:10EDGAR2Form 8-K - Current report
      11/13/202316:05GLOBEClearside Biomedical Announces Third Quarter 2023 Financial..
      11/08/202307:05GLOBEClearside Biomedical to Participate in Fireside Chat at the..
      11/07/202316:20GLOBEClearside Biomedical’s Versatile Suprachoroidal Injection..
      11/03/202312:01EDGAR2Form 8-K - Current report
      11/03/202312:00GLOBEBioCryst and Clearside Biomedical Enter Partnership to..
      11/02/202307:05GLOBEClearside Biomedical Announces Presentations at the American..
      11/01/202307:05GLOBEClearside Biomedical Completes Recruitment in ODYSSEY Phase..
      10/31/202307:05GLOBEClearside Biomedical to Report Third Quarter 2023 Financial..
      10/16/202307:05GLOBEClearside Biomedical Positive OASIS and Extension Study Data..
      10/04/202309:00GLOBEClearside Biomedical Announces Advancement of XIPERE® in..
      10/03/202316:35GLOBEClearside Biomedical to Participate in a Panel Discussion at..
      9/29/202316:46EDGAR2Form 8-K - Current report
      9/25/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/22/202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/20/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/19/202307:05GLOBEClearside Biomedical to Participate in Panel Discussion at..
      9/13/202318:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/14/202316:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/14/202316:11EDGAR2Form 8-K - Current report
      8/14/202316:05GLOBEClearside Biomedical Announces Second Quarter 2023 Financial..
      8/02/202316:30GLOBEClearside Biomedical to Participate in Upcoming Investor..
      8/01/202307:05GLOBEClearside Biomedical to Report Second Quarter 2023 Financial..
      7/31/202307:05GLOBEClearside Biomedical Highlights Excellent Safety Profile of..
      7/20/202307:05GLOBEClearside Biomedical’s Suprachoroidal Injection Platform to..
      7/17/202307:05GLOBEClearside Biomedical Announces Enrollment of Multiple..
      7/11/202316:05GLOBEClearside Biomedical CEO George Lasezkay to Present at the..
      7/10/202307:05GLOBEClearside Biomedical Asia-Pacific Partner Arctic Vision..
      6/01/202307:05GLOBEClearside Biomedical Opens Enrollment in ODYSSEY Phase 2b..
      5/11/202307:05GLOBEClearside Biomedical Announces First Quarter 2023 Financial..
      5/09/202316:30GLOBEClearside Biomedical to Participate in a Fireside Chat at..
      5/02/202307:05GLOBEClearside Biomedical to Report First Quarter 2023 Financial..
      4/27/202307:05GLOBEClearside Biomedical Presents Compelling Data at The..

      Your Recent History

      NASDAQ
      CLSD
      Clearside Biomedical
      Delayed Upgrade Clock